MLYS · CIK 0001933414 · operating
Mineralys Therapeutics, Inc. (MLYS) is a pharmaceutical preparations company incorporated in DE, listed on the Nasdaq. With a market capitalization of $2.3 billion, Mineralys Therapeutics, Inc. is a mid-cap company. The stock currently trades at $29.32, up 0.21% today, with a 52-week range of $8.69–$47.65.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2024 | $-3.66 | $-3.66 | -83.9% | |
| 2023 | $-1.99 | $-1.99 | — |